22,566.00
-510.91
(-2.21%)
7,425.18
-183.20
(-2.41%)
4,240.71
-165.21
(-3.75%)
4,030.06
-90.22
(-2.190%)
4,875.28
-144.82
(-2.885%)
15,817.04
-527.04
(-3.225%)
58,895.9900
-898.6500
(-1.503%)
22/01/2025 11:26
大行報告 | 蔚小理、藥明系、電訊股、比亞迪及領展最新評級/目標價,一表盡掌握
.高盛點評蔚小理,降理想(02015)、蔚來(09866)目標卻升小鵬(09868)目標
.高盛調升藥明系目標價,其中藥明康德(02359)目標由58元升至62.4元
.大摩看好中資電訊股,皆維持超配評級



1069,,新聞,專題透視,reports